71 results
Page 2 of 4
8-K
EX-10.1
u9kf0kvogrb ziba1j
20 Jan 22
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
nl8j5135k88kxfo9qm5
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
8-K
rbx4e0abw3
20 May 21
Departure of Directors or Certain Officers
4:12pm
10-Q
2oadml0k
12 May 21
Quarterly report
4:26pm
DEF 14A
h3d2d
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
mwdg4u02
9 Apr 21
Preliminary proxy
4:16pm
424B4
pfzzuv 0aewjo3
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
qyg 2dcuxfrr142dfo45
25 Mar 21
Draft registration statement
12:00am
10-K
eks 8dhcl
22 Mar 21
Annual report
4:22pm
8-K
EX-1.1
7ct1olcmq 23wn
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
S-8
EX-10.2
8yonnneq8
23 Nov 20
Registration of securities for employees
5:06pm
424B4
vajqc33tusur402wh 5w
23 Nov 20
Prospectus supplement with pricing info
4:36pm